Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD10 positive thyroid marginal zone non-Hodgkin lymphoma.

E K Millar1, S Waldron, A Spencer

  • 1Department of Anatomical Pathology, John Hunter Hospital, Hunter Region Mail Centre, Lambton, Australia. emillar@doh.health.nsw.gov.au

Journal of Clinical Pathology
|February 26, 2000
PubMed
Summary

A rare case of marginal zone lymphoma in the thyroid gland was diagnosed in a 72-year-old woman. This lymphoma aberrantly expressed CD10, a marker typically seen in follicle center cell lymphomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the backseat: Analyzing motorcycle passenger injuries in children.

American journal of surgery·2025
Same author

Urinary incontinence and female genital lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Reply to 'EuroGuiderm Guideline on lichen sclerosus-introduction into lichen sclerosus'.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Reply to 'EuroGuiderm guideline on lichen sclerosus-Treatment of lichen sclerosus'.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Response adaptive salvage treatment with daratumumab-lenalidomide-dexamethasone for newly diagnosed transplant-eligible multiple myeloma patients failing front-line bortezomib-based induction therapy-ALLG MM21.

British journal of haematology·2024

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Thyroid lymphomas are rare, with extranodal marginal zone B-cell lymphoma (EMZL) being the most common type.
  • Follicle center cell lymphoma (FCCL) is typically associated with CD10 expression, aiding in its diagnosis.
  • Marginal zone lymphomas (MZLs) are a heterogeneous group of B-cell neoplasms characterized by their origin from marginal zone B cells.

Observation:

  • A 72-year-old woman presented with a swollen right thyroid lobe.
  • Fine needle aspiration and flow cytometry revealed a clonal B-cell population expressing CD10.
  • Histological examination of the excised thyroid confirmed marginal zone non-Hodgkin lymphoma.

Findings:

  • The lymphoma exhibited aberrant CD10 positivity and LN1 (CDw75) expression.

Related Experiment Videos

  • Polymerase chain reaction excluded the common t(14;18) translocation associated with some lymphomas.
  • This case represents the second reported instance of CD10 aberrant expression in marginal zone lymphoma.

    • Implications:

    • Aberrant CD10 expression in marginal zone lymphoma can complicate differential diagnosis, potentially mimicking follicle center cell lymphoma.
    • Accurate diagnosis relies on a combination of flow cytometry, immunohistochemistry, and molecular studies.
    • Understanding unusual immunophenotypes in lymphomas is crucial for accurate diagnosis and appropriate patient management.